These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


269 related items for PubMed ID: 1824777

  • 1. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF.
    Fu YX, Watson GA, Kasahara M, Lopez DM.
    J Immunol; 1991 Jan 15; 146(2):783-9. PubMed ID: 1824777
    [Abstract] [Full Text] [Related]

  • 2. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.
    Fu YX, Watson G, Jimenez JJ, Wang Y, Lopez DM.
    Cancer Res; 1990 Jan 15; 50(2):227-34. PubMed ID: 2136804
    [Abstract] [Full Text] [Related]

  • 3. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM, Fu YX, Lopez-Cepero M, Herbert L, Jimenez JJ, Albarracin C, Lopez DM.
    J Immunol; 1991 Oct 15; 147(8):2816-23. PubMed ID: 1918995
    [Abstract] [Full Text] [Related]

  • 4. Epidermal Langerhans cells from mice bearing a granulocyte macrophage-colony stimulating factor-producing mammary tumor display impaired accessory functions.
    Xie Y, Fernandez ME, Streilein JW, Lopez DM.
    Anticancer Res; 1996 Oct 15; 16(1):9-16. PubMed ID: 8615675
    [Abstract] [Full Text] [Related]

  • 5. Role of colony-stimulating factor-1 in macrophage activation in tumor-bearing mice.
    Sakata T, Iwagami S, Tsuruta Y, Teraoka H, Suzuki S, Suzuki R.
    J Immunol; 1992 Dec 15; 149(12):4002-8. PubMed ID: 1281198
    [Abstract] [Full Text] [Related]

  • 6. Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms.
    Watson GA, Fu YX, Lopez DM.
    J Leukoc Biol; 1991 Feb 15; 49(2):126-38. PubMed ID: 1991996
    [Abstract] [Full Text] [Related]

  • 7. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
    Fu Y, Paul RD, Wang Y, Lopez DM.
    J Immunol; 1989 Dec 15; 143(12):4300-7. PubMed ID: 2592775
    [Abstract] [Full Text] [Related]

  • 8. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
    Falk LA, Wahl LM, Vogel SN.
    J Immunol; 1988 Apr 15; 140(8):2652-60. PubMed ID: 3128601
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice.
    Handel-Fernandez ME, Cheng X, Herbert LM, Lopez DM.
    J Immunol; 1997 Jan 01; 158(1):280-6. PubMed ID: 8977200
    [Abstract] [Full Text] [Related]

  • 10. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.
    Tsuchiya Y, Igarashi M, Suzuki R, Kumagai K.
    J Immunol; 1988 Jul 15; 141(2):699-708. PubMed ID: 2968407
    [Abstract] [Full Text] [Related]

  • 11. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.
    Watson GA, Lopez DM.
    J Immunol; 1995 Sep 15; 155(6):3124-34. PubMed ID: 7673727
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the growth of IL-3-dependent mast cells from murine bone marrow by recombinant granulocyte macrophage-colony-stimulating factor.
    Bressler RB, Thompson HL, Keffer JM, Metcalfe DD.
    J Immunol; 1989 Jul 01; 143(1):135-9. PubMed ID: 2471732
    [Abstract] [Full Text] [Related]

  • 13. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
    Hancock WW, Pleau ME, Kobzik L.
    J Immunol; 1988 May 01; 140(9):3021-5. PubMed ID: 3129507
    [Abstract] [Full Text] [Related]

  • 14. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
    Heidenreich S, Gong JH, Schmidt A, Nain M, Gemsa D.
    J Immunol; 1989 Aug 15; 143(4):1198-205. PubMed ID: 2473121
    [Abstract] [Full Text] [Related]

  • 15. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E, Aruga A, Arca MJ, Lee WM, Yang NS, Smith JW, Chang AE.
    Cancer Gene Ther; 1997 Aug 15; 4(3):157-66. PubMed ID: 9171934
    [Abstract] [Full Text] [Related]

  • 16. Recombinant granulocyte-macrophage colony-stimulating factor restores deficient immune responses in mice with chronic Trypanosoma cruzi infections.
    Reed SG, Grabstein KH, Pihl DL, Morrissey PJ.
    J Immunol; 1990 Sep 01; 145(5):1564-70. PubMed ID: 2117033
    [Abstract] [Full Text] [Related]

  • 17. GM-CSF up-regulates the expression of CCL2 by T lymphocytes in mammary tumor-bearing mice.
    Owen JL, Torroella-Kouri M, Handel-Fernandez ME, Iragavarapu-Charyulu V.
    Int J Mol Med; 2007 Jul 01; 20(1):129-36. PubMed ID: 17549399
    [Abstract] [Full Text] [Related]

  • 18. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules.
    Walker TM, Burger CJ, Elgert KD.
    Oncol Res; 1992 Jul 01; 4(11-12):455-65. PubMed ID: 1299376
    [Abstract] [Full Text] [Related]

  • 19. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF, Goldwasser E, Fitch FW.
    J Immunol; 1988 Oct 15; 141(8):2635-42. PubMed ID: 2971726
    [Abstract] [Full Text] [Related]

  • 20. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X, Huang X, Ju DW, Zhang W, Hamada H, Wang J.
    Cancer Gene Ther; 2000 Feb 15; 7(2):177-86. PubMed ID: 10770625
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.